FMISO

DRUG3 trials

Sponsors

Okayama university, National Cancer Institute (NCI), University of Alabama at Birmingham

Conditions

Adult Giant Cell GlioblastomaAdult GlioblastomaAdult GliosarcomaHepatocellular Carcinomaneurological diseases

Phase 2

MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme

CompletedNCT00902577

National Cancer Institute (NCI)Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma

Start: 2009-08-24End: 2018-01-31Updated: 2019-04-08

Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging

TerminatedNCT03303469

University of Alabama at BirminghamHepatocellular Carcinoma

Start: 2017-10-30End: 2021-01-06Updated: 2021-02-21

Unknown Phase

Hypoxia imaging in the brain and spinal cord of ALS

Active, not recruitingJPRN-UMIN000026862

Okayama universityneurological diseases

Start: 2017-05-01Target: 15Updated: 2025-07-18

Related Papers

ACRIN 6684: Assessment of tumor hypoxia in newly diagnosed GBM using FMISO PET and MRI.

Journal of Clinical Oncology2015-05-201 citations